← Evidence map

ReviewPharmaceutics2021

Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation.

Eleonore FröhlichPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33562240